PATENT CLAIM ANALYSIS

Application Number: 16077803
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "228800"]

Abstract:
The present invention provides a compound of formula (I) having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compound of the present invention is useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease.

Claim (Index 7):
A method for treatment of diseases and disorders characterized by elevated \u03b2-amyloid levels and/or \u03b2-amyloid oligomers and/or \u03b2-amyloid plaques and further deposits or Alzheimer's disease, comprising the step of administering a therapeutically effective amount of a compound according to  claim 1 , or pharmaceutically acceptable salt thereof, to a patient in need thereof.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 96.0
- Lexical Diversity: 1.29268
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12852538', '14373697', '13467085', '14116043', '13439893']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7966272867554273
- 35 USC 102 Novelty (BERT): 0.5286634816285022
- Combined Prediction Score: 0.7698309062427348
- Mean Citation Score: 348.63056200000005
- Max Citation Score: 354.43246
- Similarity Product: 244.69482710617905

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test